Lange W, Köhler H
Dtsch Med Wochenschr. 1978 Nov 24;103(47):1873-7. doi: 10.1055/s-0028-1129360.
Among various modifications of the Hepanostika test a simple, sensitive and reproducible one is described as being the best. Of 689 sera from patients in a haemodialysis unit 110 had antibodies against HBs antigen in the Hepanostika test and 150 in the Ausab test. Those antibodies which were not demonstrated in the Hepanostika test had a relatively low concentration (mean impulses per minutes 4.3 X NCx). Those sera which were positive in both the Hepanostika and Ausab test contained antibodies in higher concentrations (mean impulse/min 29.5 X NCx). Only 11 of the 689 sera were positive in the migration-electrophoresis test. A particularly advantage of the modified Hepanostika test is that both HBs antigen and antibodies against HBs antigen can be demonstrated simultaneously on the same plate. Using this method 200 sera were examined. The same sera were tested in the Austria-II-125 test for HBs antigen and the Ausab test for antibodies against HBs antigen. The Hepanostika test was positive in five, the Austria test in four sera. According to the Hepanostika test 43 sera contained antibodies against HBs antigen, while 45 did according to the Ausab test. The two that were positive only in the Ausab test were only weakly positive.
在肝炎诊断试验(Hepanostika test)的各种改良方法中,一种简单、灵敏且可重复的方法被认为是最佳的。在一个血液透析单元的689份患者血清中,肝炎诊断试验中有110份含有抗乙肝表面抗原(HBs antigen)的抗体,澳抗(Ausab)试验中有150份。那些在肝炎诊断试验中未显示的抗体浓度相对较低(平均每分钟脉冲数4.3×正常对照值)。那些在肝炎诊断试验和澳抗试验中均呈阳性的血清含有更高浓度的抗体(平均脉冲数/分钟29.5×正常对照值)。689份血清中只有11份在迁移电泳试验中呈阳性。改良肝炎诊断试验的一个特别优点是,乙肝表面抗原和抗乙肝表面抗原的抗体可以在同一平板上同时显示。使用这种方法检测了200份血清。同样的血清分别用奥地利-II -125试验检测乙肝表面抗原,用澳抗试验检测抗乙肝表面抗原的抗体。肝炎诊断试验中有5份血清呈阳性,奥地利试验中有4份血清呈阳性。根据肝炎诊断试验,43份血清含有抗乙肝表面抗原的抗体,而根据澳抗试验则有45份。仅在澳抗试验中呈阳性的两份血清只是弱阳性。